Rob Davis | CEO |
Peter Dannenbaum | VP Investor Relations |
Dean Li | President of Merck Research Labs |
Frank Clyburn | President of Human Health |
Caroline Litchfield | CFO |
Chris Schott | JP Morgan |
Umer Raffat | Evercore ISI |
Louise Chen | Cantor |
Terrence Flynn | Goldman Sachs |
Andrew Baum | Citi |
Daina Graybosch | SVB Leerink |
Geoff Meacham | Bank of America |
Ronny Gal | Bernstein |
Mara Goldstein | Mizuho |
Carter Gould | Barclays |
Steve Scala | Cowen |
Good morning. My name is Mary Serran (ph), and I will be your conference operator today. At this time, I would like to welcome everyone to the Merck and Co.
Second Quarter 2021 Conference Call. All lines have been placed on mute to prevent any background noise.